Crispr Therapeutics shares owned by Blackstone Group
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Blackstone Group
from 13F filings
Historical chart of Blackstone Group investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Blackstone Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Blackstone Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $764k | 12k | 62.60 |
| 2023-09-30 | $554k | 12k | 45.39 |
| 2023-06-30 | $685k | 12k | 56.14 |
| 2023-03-31 | $552k | 12k | 45.23 |
| 2022-12-31 | $496k | 12k | 40.65 |
| 2022-09-30 | $797k | 12k | 65.35 |
| 2022-06-30 | $741k | 12k | 60.76 |
| 2022-03-31 | $766k | 12k | 62.81 |
| 2021-12-31 | $924k | 12k | 75.76 |
| 2021-09-30 | $1.4M | 12k | 111.92 |